| Product Code: ETC7544368 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India geriatric medicines market import shipments witnessed a steady expansion over the period 2020-2024, with a notable CAGR of 7.7%. The growth momentum notably accelerated between 2023 and 2024, surging by 55.0%. This indicates a robust and accelerating upward trend in the market's import activity.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Geriatric Medicines Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Geriatric Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 India Geriatric Medicines Market - Industry Life Cycle |
3.4 India Geriatric Medicines Market - Porter's Five Forces |
3.5 India Geriatric Medicines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 India Geriatric Medicines Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 India Geriatric Medicines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Geriatric Medicines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Geriatric Medicines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Geriatric Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing geriatric population in India |
4.2.2 Rising prevalence of chronic diseases among the elderly |
4.2.3 Government initiatives to improve healthcare access for the elderly |
4.3 Market Restraints |
4.3.1 Affordability and accessibility issues for geriatric medicines |
4.3.2 Lack of awareness and education among the elderly population |
4.3.3 Stringent regulatory requirements for geriatric medicines |
5 India Geriatric Medicines Market Trends |
6 India Geriatric Medicines Market, By Types |
6.1 India Geriatric Medicines Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 India Geriatric Medicines Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 India Geriatric Medicines Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.1.4 India Geriatric Medicines Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.1.5 India Geriatric Medicines Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.1.6 India Geriatric Medicines Market Revenues & Volume, By Neurological, 2021- 2031F |
6.1.7 India Geriatric Medicines Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.8 India Geriatric Medicines Market Revenues & Volume, By Osteoporosis, 2021- 2031F |
6.1.9 India Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 India Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Geriatric Medicines Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 India Geriatric Medicines Market Revenues & Volume, By Analgesic, 2021- 2031F |
6.2.3 India Geriatric Medicines Market Revenues & Volume, By Antihypertensive, 2021- 2031F |
6.2.4 India Geriatric Medicines Market Revenues & Volume, By Statins, 2021- 2031F |
6.2.5 India Geriatric Medicines Market Revenues & Volume, By Antidiabetic, 2021- 2031F |
6.2.6 India Geriatric Medicines Market Revenues & Volume, By Proton Pump Inhibitor, 2021- 2031F |
6.2.7 India Geriatric Medicines Market Revenues & Volume, By Anticoagulant, 2021- 2031F |
6.3 India Geriatric Medicines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Geriatric Medicines Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Geriatric Medicines Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Geriatric Medicines Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Geriatric Medicines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Geriatric Medicines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 India Geriatric Medicines Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 India Geriatric Medicines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Geriatric Medicines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Geriatric Medicines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Geriatric Medicines Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 India Geriatric Medicines Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Geriatric Medicines Market Import-Export Trade Statistics |
7.1 India Geriatric Medicines Market Export to Major Countries |
7.2 India Geriatric Medicines Market Imports from Major Countries |
8 India Geriatric Medicines Market Key Performance Indicators |
8.1 Average age of the population |
8.2 Percentage of the population covered by health insurance |
8.3 Number of geriatric healthcare facilities in India |
9 India Geriatric Medicines Market - Opportunity Assessment |
9.1 India Geriatric Medicines Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 India Geriatric Medicines Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 India Geriatric Medicines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Geriatric Medicines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Geriatric Medicines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Geriatric Medicines Market - Competitive Landscape |
10.1 India Geriatric Medicines Market Revenue Share, By Companies, 2024 |
10.2 India Geriatric Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here